Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Mycoses"
DOI: 10.1111/myc.13495
Abstract: Patients undergoing induction/reinduction chemotherapy for haematologic malignancies (HM) are at risk for invasive fungal infections (IFIs). In 2015, Duke University Hospital (DUH) implemented a new standardised fungal prophylaxis protocol for adult patients undergoing induction chemotherapy… read more here.
Keywords: prophylaxis posaconazole; effectiveness antifungal; world effectiveness; antifungal prophylaxis ... See more keywords